driving preemptive clinical intervention · ©2015 immucor, inc. call: 262.754.1058 email:...
TRANSCRIPT
![Page 1: Driving Preemptive Clinical Intervention · ©2015 Immucor, Inc. Call: 262.754.1058 Email: SORT@immucor.com kSORT predicts potentially irreversible damage to the allograft 3-4 months](https://reader033.vdocuments.site/reader033/viewer/2022060218/5f06910e7e708231d418a06b/html5/thumbnails/1.jpg)
kSORT is a non-invasive, accurate and precise genomic blood test for monitoring renal transplant rejection and surveillance.
Driving Preemptive Clinical Intervention
Transfuse | Transplant | Transform a life
IMM_636_kSORT_SellSheet_Redesign_2Pg_Final.indd 1 8/10/15 4:07 PM
![Page 2: Driving Preemptive Clinical Intervention · ©2015 Immucor, Inc. Call: 262.754.1058 Email: SORT@immucor.com kSORT predicts potentially irreversible damage to the allograft 3-4 months](https://reader033.vdocuments.site/reader033/viewer/2022060218/5f06910e7e708231d418a06b/html5/thumbnails/2.jpg)
©2015 Immucor, Inc.
Call: 262.754.1058Email: [email protected]
kSORT predicts potentially irreversible damage to the allograft 3-4 months before current diagnostic tools •Creatininelevelsandbiopsiesarebothlateindicatorsofinjury
•Bythetimecreatininelevelsareelevated,morethan50%ofkidneyfunctionmaybelost.Creatininelevelsarenothighlyspecificorsensitiveintheirreliabilitytodetectclinicallyrelevantevents.
•Biopsies,thecurrentgoldstandardforassessinggraftstatus,areinvasive,painful,inconvenientandunsuitedforserialmonitoring.Biopsiesyieldinconclusiveresultsasoftenas30%ofthetime.
•kSORTisasurveillanceandmonitoringassayclinicianscanutilizetomeasurealloimmuneresponseovertime.
kSORT: TheNewParadigminPersonalizedTransplantManagement
Cancer/InfectionsOrgan ToxicityMetabolic Disturbance
Acute Cellular Rejection (ACR)Antibody Mediated Rejection (AMR)
IMM_636_kSORT_SellSheet_Redesign_2Pg_Final.indd 2 8/10/15 4:07 PM